Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections

Christopher Toon, Benjamin Allanson, Connull Leslie, Nathan Acott, Bob Mirzai, Spiro Raftopoulos, Marian Priyanthi Kumarasinghe

Research output: Contribution to journalArticle

Abstract

There is increasing interest in p53 immunohistochemistry as an adjunct to haematoxylin and eosin (H&E) assessment for dysplasia in oesophageal Barrett's mucosa; however, published information on the patterns of staining remains scant. Here, we present descriptions of normal and aberrant p53 staining in non-neoplastic and dysplastic Barrett's mucosa in endoscopic mucosal resections. A retrospective series of archival endoscopic mucosal resections for biopsy proven dysplasia at our institution were retrieved for this study, comprising 28 sections from 23 patients. p53 immunohistochemistry was performed using an in-house optimised protocol and the staining pattern assessed in H&E confirmed non-neoplastic, dysplastic and neoplastic areas of Barrett's mucosa with regard to individual cell intensity and location of positive cells with respect to gland microanatomy. In non-neoplastic epithelium, normal p53 staining was weak, heterogenous and localised to the crypts. In dysplastic epithelium, p53 over-expression was seen which was of moderate to strong intensity in either a crypt predominant location or diffuse involving crypt and surface epithelium. The crypt predominant pattern was observed more commonly in low grade dysplasia while the diffuse pattern was more commonly seen in high grade dysplasia. In a minority of cases, there was complete loss of p53 staining in dysplastic epithelium and contiguous neoplasia (null phenotype). p53 immuno-expression in non-neoplastic and dysplastic Barrett's mucosa is distinctive when interpreted with regard to cell intensity and gland microanatomy. We propose that these staining patterns may assist in the interpretation of dysplasia in endoscopic biopsies of Barrett's mucosa.

Original languageEnglish
Pages (from-to)253-260
Number of pages8
JournalPathology
Volume51
Issue number3
DOIs
Publication statusPublished - 1 Apr 2019

Fingerprint

Barrett Esophagus
Mucous Membrane
Staining and Labeling
Epithelium
Immunohistochemistry
Biopsy
Hematoxylin
Eosine Yellowish-(YS)
Endoscopic Mucosal Resection
Phenotype
Neoplasms

Cite this

Toon, Christopher ; Allanson, Benjamin ; Leslie, Connull ; Acott, Nathan ; Mirzai, Bob ; Raftopoulos, Spiro ; Kumarasinghe, Marian Priyanthi. / Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus : in-depth evaluation in endoscopic mucosal resections. In: Pathology. 2019 ; Vol. 51, No. 3. pp. 253-260.
@article{f62a4e9e9849453ca99f25110e15ffdb,
title = "Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections",
abstract = "There is increasing interest in p53 immunohistochemistry as an adjunct to haematoxylin and eosin (H&E) assessment for dysplasia in oesophageal Barrett's mucosa; however, published information on the patterns of staining remains scant. Here, we present descriptions of normal and aberrant p53 staining in non-neoplastic and dysplastic Barrett's mucosa in endoscopic mucosal resections. A retrospective series of archival endoscopic mucosal resections for biopsy proven dysplasia at our institution were retrieved for this study, comprising 28 sections from 23 patients. p53 immunohistochemistry was performed using an in-house optimised protocol and the staining pattern assessed in H&E confirmed non-neoplastic, dysplastic and neoplastic areas of Barrett's mucosa with regard to individual cell intensity and location of positive cells with respect to gland microanatomy. In non-neoplastic epithelium, normal p53 staining was weak, heterogenous and localised to the crypts. In dysplastic epithelium, p53 over-expression was seen which was of moderate to strong intensity in either a crypt predominant location or diffuse involving crypt and surface epithelium. The crypt predominant pattern was observed more commonly in low grade dysplasia while the diffuse pattern was more commonly seen in high grade dysplasia. In a minority of cases, there was complete loss of p53 staining in dysplastic epithelium and contiguous neoplasia (null phenotype). p53 immuno-expression in non-neoplastic and dysplastic Barrett's mucosa is distinctive when interpreted with regard to cell intensity and gland microanatomy. We propose that these staining patterns may assist in the interpretation of dysplasia in endoscopic biopsies of Barrett's mucosa.",
keywords = "Barrett's mucosa, dysplasia, p53 immunohistochemistry",
author = "Christopher Toon and Benjamin Allanson and Connull Leslie and Nathan Acott and Bob Mirzai and Spiro Raftopoulos and Kumarasinghe, {Marian Priyanthi}",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.pathol.2018.12.415",
language = "English",
volume = "51",
pages = "253--260",
journal = "Pathology",
issn = "0031-3025",
publisher = "Pergamon",
number = "3",

}

Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus : in-depth evaluation in endoscopic mucosal resections. / Toon, Christopher; Allanson, Benjamin; Leslie, Connull; Acott, Nathan; Mirzai, Bob; Raftopoulos, Spiro; Kumarasinghe, Marian Priyanthi.

In: Pathology, Vol. 51, No. 3, 01.04.2019, p. 253-260.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus

T2 - in-depth evaluation in endoscopic mucosal resections

AU - Toon, Christopher

AU - Allanson, Benjamin

AU - Leslie, Connull

AU - Acott, Nathan

AU - Mirzai, Bob

AU - Raftopoulos, Spiro

AU - Kumarasinghe, Marian Priyanthi

PY - 2019/4/1

Y1 - 2019/4/1

N2 - There is increasing interest in p53 immunohistochemistry as an adjunct to haematoxylin and eosin (H&E) assessment for dysplasia in oesophageal Barrett's mucosa; however, published information on the patterns of staining remains scant. Here, we present descriptions of normal and aberrant p53 staining in non-neoplastic and dysplastic Barrett's mucosa in endoscopic mucosal resections. A retrospective series of archival endoscopic mucosal resections for biopsy proven dysplasia at our institution were retrieved for this study, comprising 28 sections from 23 patients. p53 immunohistochemistry was performed using an in-house optimised protocol and the staining pattern assessed in H&E confirmed non-neoplastic, dysplastic and neoplastic areas of Barrett's mucosa with regard to individual cell intensity and location of positive cells with respect to gland microanatomy. In non-neoplastic epithelium, normal p53 staining was weak, heterogenous and localised to the crypts. In dysplastic epithelium, p53 over-expression was seen which was of moderate to strong intensity in either a crypt predominant location or diffuse involving crypt and surface epithelium. The crypt predominant pattern was observed more commonly in low grade dysplasia while the diffuse pattern was more commonly seen in high grade dysplasia. In a minority of cases, there was complete loss of p53 staining in dysplastic epithelium and contiguous neoplasia (null phenotype). p53 immuno-expression in non-neoplastic and dysplastic Barrett's mucosa is distinctive when interpreted with regard to cell intensity and gland microanatomy. We propose that these staining patterns may assist in the interpretation of dysplasia in endoscopic biopsies of Barrett's mucosa.

AB - There is increasing interest in p53 immunohistochemistry as an adjunct to haematoxylin and eosin (H&E) assessment for dysplasia in oesophageal Barrett's mucosa; however, published information on the patterns of staining remains scant. Here, we present descriptions of normal and aberrant p53 staining in non-neoplastic and dysplastic Barrett's mucosa in endoscopic mucosal resections. A retrospective series of archival endoscopic mucosal resections for biopsy proven dysplasia at our institution were retrieved for this study, comprising 28 sections from 23 patients. p53 immunohistochemistry was performed using an in-house optimised protocol and the staining pattern assessed in H&E confirmed non-neoplastic, dysplastic and neoplastic areas of Barrett's mucosa with regard to individual cell intensity and location of positive cells with respect to gland microanatomy. In non-neoplastic epithelium, normal p53 staining was weak, heterogenous and localised to the crypts. In dysplastic epithelium, p53 over-expression was seen which was of moderate to strong intensity in either a crypt predominant location or diffuse involving crypt and surface epithelium. The crypt predominant pattern was observed more commonly in low grade dysplasia while the diffuse pattern was more commonly seen in high grade dysplasia. In a minority of cases, there was complete loss of p53 staining in dysplastic epithelium and contiguous neoplasia (null phenotype). p53 immuno-expression in non-neoplastic and dysplastic Barrett's mucosa is distinctive when interpreted with regard to cell intensity and gland microanatomy. We propose that these staining patterns may assist in the interpretation of dysplasia in endoscopic biopsies of Barrett's mucosa.

KW - Barrett's mucosa

KW - dysplasia

KW - p53 immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=85062010350&partnerID=8YFLogxK

U2 - 10.1016/j.pathol.2018.12.415

DO - 10.1016/j.pathol.2018.12.415

M3 - Article

VL - 51

SP - 253

EP - 260

JO - Pathology

JF - Pathology

SN - 0031-3025

IS - 3

ER -